Impact of diabetes on long-term outcome after primary angioplasty: insights from the DESERT cooperation.
about
Comparing the effectiveness and safety between triple antiplatelet therapy and dual antiplatelet therapy in type 2 diabetes mellitus patients after coronary stents implantation: a systematic review and meta-analysis of randomized controlled trialsDiabetes and Adverse Cardiovascular Outcomes in Patients with Acute Coronary Syndrome - Data from Taiwan's Acute Coronary Syndrome Full Spectrum Data Registry.Endovascular Gene Delivery from a Stent Platform: Gene- Eluting Stents.Inhibition of DPP-4 reduces acute mortality after myocardial infarction with restoration of autophagic response in type 2 diabetic rats.Stent thrombosis and adverse cardiovascular outcomes observed between six months and five years with sirolimus-eluting stents and other drug-eluting stents in patients with Type 2 diabetes mellitus complicated by coronary artery disease: A systematiImpact of diabetes on bleeding events in ST-elevation myocardial infarction patients after urgent percutaneous coronary intervention: A retrospective cohort study.Paclitaxel-eluting versus bare metal stents in primary PCI: a pooled patient-level meta-analysis of randomized trials.Platelet GP IIb-IIIa Receptor Antagonists in Primary Angioplasty: Back to the Future.Third generation drug eluting stent (DES) with biodegradable polymer in diabetic patients: 5 years follow-up.Long-term mortality after acute myocardial infarction among individuals with and without diabetes: A systematic review and meta-analysis of studies in the post-reperfusion era.Impact of diabetes on immature platelets fraction and its relationship with platelet reactivity in patients receiving dual antiplatelet therapy.A Randomized Trial of Complete Versus Culprit-Only Revascularization During Primary Percutaneous Coronary Intervention in Diabetic Patients With Acute ST Elevation Myocardial Infarction and Multi Vessel Disease.Impact of diabetes on the benefits from everolimus-eluting stent as compared to first-generation drug-eluting stent in patients with ST elevation myocardial infarction.The Management and Prognostic Factors of Acute Coronary Syndrome: Evidence from the Taiwan Acute Coronary Syndrome Full Spectrum Registry.Outcomes in diabetic patients undergoing primary percutaneous coronary intervention for acute anterior myocardial infarction: results from the INFUSE-AMI study.Outcomes of primary percutaneous coronary intervention in acute myocardial infarction due to unprotected left main thrombosis: The Asia-Pacific Left Main ST-Elevation Registry (ASTER).Effect of diabetes on scintigraphic infarct size in STEMI patients undergoing primary angioplasty.Relationship between diabetes and ischaemic injury among patients with revascularized ST-elevation myocardial infarction.Effect of diabetes mellitus on periprocedural myocardial infarction in patients undergoing coronary stent implantation.Platelet Larger Cell Ratio and High-on Treatment Platelet Reactivity During Dual Antiplatelet Therapy.Neutrophil to Lymphocyte Ratio and the Extent of Coronary Artery Disease: Results From a Large Cohort Study.Impact of type 2 diabetes mellitus on recurrent myocardial infarction in China.Empagliflozin normalizes the size and number of mitochondria and prevents reduction in mitochondrial size after myocardial infarction in diabetic hearts.
P2860
Q26785723-4F4030A1-7861-4AD2-AAF7-BCDC3B8C348CQ31095615-B1415B5A-4D1B-4BC3-BD4C-EEBE9079AAACQ35893044-166004AD-223D-4855-B43C-B5B5C0DC519AQ35936441-E1038E51-5617-4D49-AC0F-1D0ADDB0BBB9Q37328131-4880F53D-21AA-4DAF-BA40-AFFA8AF5DAD1Q37726684-F92FE970-D44F-464E-A556-6B00D26EB950Q38223494-39A19F6F-F6FD-49FE-8F2D-66AAF769C8CAQ38547727-9C0ABCD4-0004-4463-A48C-322A6E8796E8Q38969182-1DD0C726-C4D4-4BB4-9194-978F76B555CFQ39013114-A83E4CB6-376D-47B6-A57E-D0C6D7E5A6A6Q39941820-8DDCC977-0370-414B-8D4B-AE779BE2F2A9Q40726736-FB2ECBAF-CF56-440C-A58C-77D9A7D5794BQ40762800-B745B0DB-7438-4BE5-A5AF-79B09C53AEFDQ42339373-28F49873-F942-4C43-AC04-259967E7AFB6Q43652562-30200A33-6F91-4975-8577-A8BBC3F6120CQ46819235-1C6FA057-10BD-44FB-A3F0-9262C56A462DQ47426386-E107567B-A3EB-4D83-9F2F-A97F248200DEQ48186418-49230B2F-5DC6-4FA6-AC15-5A499D14F645Q51321413-444CFF1D-B6CB-4F92-9032-333D44F33934Q52912700-6FFB5B53-B2F2-4E9A-94BE-5223FB74CD0CQ52955572-0D833DC4-0C8A-4428-AC7A-35847C054E41Q53064964-CAE5A4C0-96C4-48F4-AC5E-B5B2F84FC2F8Q55384960-CEADCE1B-902F-46EE-B1C6-D3DF6EE5BCC1
P2860
Impact of diabetes on long-term outcome after primary angioplasty: insights from the DESERT cooperation.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Impact of diabetes on long-ter ...... s from the DESERT cooperation.
@ast
Impact of diabetes on long-ter ...... s from the DESERT cooperation.
@en
type
label
Impact of diabetes on long-ter ...... s from the DESERT cooperation.
@ast
Impact of diabetes on long-ter ...... s from the DESERT cooperation.
@en
prefLabel
Impact of diabetes on long-ter ...... s from the DESERT cooperation.
@ast
Impact of diabetes on long-ter ...... s from the DESERT cooperation.
@en
P2093
P2860
P356
P1433
P1476
Impact of diabetes on long-ter ...... s from the DESERT cooperation.
@en
P2093
Bas van der Hoeven
Carmine Musto
Christian Spaulding
Christoph Kaiser
DESERT cooperation
Emilio Di Lorenzo
Gaia Spaziani
Giuseppe De Luca
Gregg W Stone
Harry Suryapranata
P2860
P304
P356
10.2337/DC12-1507
P407
P577
2012-12-28T00:00:00Z